Reading this on a mobile device? Try our optimized mobile version here:

October 30, 2012
Sign upForwardArchiveAdvertise
News for Invasive/Interventional Cardiologists

  Top Stories 
  • Trial quantifies quality-of-life, cost benefits of FFR-guided PCI
    Fractional flow reserve-guided percutaneous coronary intervention is cost-effective and improves quality of life when compared with medical management in stable patients who have flow-limiting coronary lesions, according to results from the FAME II trial. Researchers found similar outcomes for rates of mortality and myocardial infarction but a significantly lower rate of urgent revascularization at the two-year mark for PCI patients. (Montreal) (free registration) (10/24) LinkedInFacebookTwitterEmail this Story
  • Other News
  Policy & Professional News 
  • Strategies for appropriate use in the cath lab
    Interventional cardiologist Dr. David Wohns, who serves as medical director of the catheterization lab at Spectrum Health in Grand Rapids, Mich., discusses strategies to ensure appropriate use of procedures and resources. Securing support among physicians, establishing random case reviews, participating in a registry and adopting external evaluations such as Accreditation for Cardiovascular Excellence are all practices that can help organizations take a proactive approach to ensuring appropriate use, Wohns says. (10/24) LinkedInFacebookTwitterEmail this Story
  • Agency publishes 2014 MU clinical quality measures
    CMS has released the final 2014 clinical quality measures for eligible health care providers, hospitals and critical access facilities participating in either stage 1 or stage 2 meaningful use. The agency has also posted a variety of resources to help clarify the measures. Healthcare IT News (10/26) LinkedInFacebookTwitterEmail this Story
  Medical Developments 
  • Analyses favor PCI for lower stroke risk
    Data discussed at TCT 2012 indicate percutaneous coronary intervention may carry a lower risk of stroke than coronary artery bypass graft surgery. Two meta-analyses found lower stroke rates associated with PCI at the 30-day and one-year marks. (10/22) LinkedInFacebookTwitterEmail this Story
  • Researchers see benefits, little risk from renal denervation
    The use of renal nerve ablation to treat refractory high blood pressure appears to carry long-term benefits with little risk of adverse events, according to researchers from Australia's Baker Heart and Diabetes Institute in Melbourne who reported the findings at TCT 2012. Within a month, 69% of patients demonstrated a response to the treatment, and at the three-year mark, 94% of remaining study participants had responded. MedPage Today (free registration) (10/24) LinkedInFacebookTwitterEmail this Story
  • Study: CPR administration varies by neighborhood
    Cardiac arrest patients are less likely to get CPR from a bystander in low-income neighborhoods than in more affluent areas, according to an analysis of more than 14,000 cases published in the New England Journal of Medicine. Patients were half as likely to get CPR from a bystander in low-income, mostly black areas than in more affluent, predominantly white neighborhoods, and the trend held in poor white and Latino areas, too. Those who did receive CPR from a bystander had twice the chance of surviving the event, researchers said. The New York Times (tiered subscription model)/Well blog (10/26) LinkedInFacebookTwitterEmail this Story
  SCAI News 
  • teams up with Mended Little Hearts on free webinar for patients
    Dennis P. Kim, M.D., Ph.D., FSCAI, associate editor-in-chief of SCAI's public education website,, will host a free webinar for the families of children and adults with congenital heart disease. Focused on transcatheter valve replacement, the webinar is part of an educational series offered by Mended Little Hearts to answer parents' questions about which patients are good candidates for the procedure, the benefits and risks, and the circumstances under which insurance companies will cover it. The webinar will include ample time for Q&A with Dr. Kim. Encourage your patients to register today! LinkedInFacebookTwitterEmail this Story
Learn more about SCAI ->Join SCAI  |  SCAI 2013  |  SCAI Education & Meetings  |  SCAI e-Learning
Advocacy Update  |  Information for Your Patients

A teacher affects eternity; he can never tell where his influence stops."
--Henry Adams,
American journalist, historian, academic and novelist

LinkedInFacebookTwitterEmail this Story

The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.

The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent SCAI SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information